Van Wauwe J, Aerts F, Walter H, de Boer M
Janssen Research Foundation, Beerse, Belgium.
Inflamm Res. 1995 Sep;44(9):400-5. doi: 10.1007/BF01797868.
The ability of dexamethasone and prednisolone (corticosteroids), FK506 and cyclosporin A (T cell immunosuppressants), and of nitraquazone and rolipram (phosphodiesterase IV inhibitors) to inhibit cytokine production by stimulated human blood was investigated. Heparinized human blood obtained from normal healthy volunteers was stimulated with phytohemagglutinin (PHA) in the presence or absence of drug. After different incubation times, supernatant levels of interleukin (IL)-2, IL-5, granulocyte-macrophage colony stimulating factor (GM-CSF) and interferon gamma (IFN-gamma) were quantified by ELISA. Dexamethasone strongly inhibited the production of IL-5 (IC50 = 0.004 microM), was less potent against IL-2 and IFN-gamma (IC50 = 0.02-0.05 microM) and showed a relatively weak effect against GM-CSF (IC50 = 0.6 microM). Similarly prednisolone potently suppressed IL-5 generation (IC50 = 0.05 microM), displayed a more modest activity on IL-2 and IFn-gamma (IC50 = 0.2-0.3 microM) and exerted only partial effects (43% inhibition at 1 microM) on GM-CSF). FK506 strongly suppressed the production of IL-2 (IC50 = 0.01 microM) and GM-CSF (IC50 = 0.03 microM), but was inactive (< 30% inhibition at 1 microM) against IL-5 and IFN-gamma. Similarly, cyclosporin A reduced the generation of IL-2 (IC50 = 0.4 microM) and GM-CSF (IC50 = 0.6 microM) while barely affecting the other two cytokines. Nitraquazone and rolipram were most active in reducing the production of IL-5 (IC50 = 0.8 and 1.3 microM, respectively), while their potency against IL-2, GM-CSF and IFN-gamma was 3-6 times lower, with IC50's between 2.4 and 8.0 microM. These data indicate that corticosteroids, T cell immunosuppressants and phosphodiesterase IV inhibitors affect cytokine production by PHA-stimulated human blood cells in a differential and "pharmacotypical'' manner.
研究了地塞米松和泼尼松龙(皮质类固醇)、FK506和环孢素A(T细胞免疫抑制剂)以及硝喹宗和咯利普兰(磷酸二酯酶IV抑制剂)抑制人全血经刺激后细胞因子产生的能力。在有或无药物存在的情况下,用植物血凝素(PHA)刺激从正常健康志愿者获得的肝素化人全血。在不同的孵育时间后,通过酶联免疫吸附测定法(ELISA)对白细胞介素(IL)-2、IL-5、粒细胞-巨噬细胞集落刺激因子(GM-CSF)和干扰素γ(IFN-γ)的上清液水平进行定量。地塞米松强烈抑制IL-5的产生(IC50 = 0.004 microM),对IL-2和IFN-γ的抑制作用较弱(IC50 = 0.02 - 0.05 microM),对GM-CSF的作用相对较弱(IC50 = 0.6 microM)。同样,泼尼松龙有效抑制IL-5的产生(IC50 = 0.05 microM),对IL-2和IFN-γ的活性较低(IC50 = 0.2 - 0.3 microM),对GM-CSF仅产生部分作用(1 microM时抑制43%)。FK506强烈抑制IL-2(IC50 = 0.01 microM)和GM-CSF(IC50 = 0.03 microM)的产生,但对IL-5和IFN-γ无活性(1 microM时抑制< 30%)。同样,环孢素A减少IL-2(IC50 = 0.4 microM)和GM-CSF(IC50 = 0.6 microM)的产生,而对另外两种细胞因子几乎没有影响。硝喹宗和咯利普兰在减少IL-5产生方面最有效(IC50分别为0.8和1.3 microM),而它们对IL-2、GM-CSF和IFN-γ的效力低3 - 6倍,IC50在2.4和8.0 microM之间。这些数据表明,皮质类固醇、T细胞免疫抑制剂和磷酸二酯酶IV抑制剂以不同的“药物典型”方式影响PHA刺激的人血细胞产生细胞因子。